Figure 3.
A total of 3 invasion-associated extracellular matrix components demonstrated significantly different expression levels in the samples from different prognostic groups. All 3 molecules had increased expression in patients in group A, indicating that the level of these molecules was associated with tumor invasiveness and patient survival. Group A, OS <24 months; group B, OS >24 month.; FLT4, Fms-related tyrosine kinase 4; MDM2, murine double minute 2; MMP-2, matrix metallopeptidase 2; rel., relative; OS, overall survival.